ATHE
Alterity Therapeutics Ltd
NASDAQ: ATHE · HEALTHCARE · BIOTECHNOLOGY
$4.83
-2.52% today
Updated 2026-06-01
Market cap
$88.31M
P/E ratio
—
P/S ratio
13.31x
EPS (TTM)
$-0.60
Dividend yield
—
52W range
$3 – $7
Volume
0.0M
Alterity Therapeutics Ltd (ATHE) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+100.0%
Last 4 quarters
Revenue YoY growth
+402.4%
Most recent quarter
EPS YoY growth
—
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-06-30 | $-0.67 | $0.00 | +100.0% | $3.83M | — |
| 2024-12-31 | $-0.11 | $0.00 | +100.0% | $1.61M | — |
| 2023-03-31 | $0.00 | $0.00 | — | $765247.00 | — |
| 2022-12-31 | $-1.80 | $0.00 | +100.0% | $2.39M | — |
| 2022-09-30 | $0.00 | $0.00 | — | $762980.00 | — |
| 2022-06-30 | $-0.24 | $-0.24 | +0.0% | — | — |
| 2022-03-31 | $0.00 | $0.00 | — | — | — |
| 2021-12-31 | $0.00 | $0.00 | — | — | — |
| 2021-09-30 | $0.00 | $0.00 | — | — | — |
| 2021-06-30 | $-0.17 | $-0.13 | +22.4% | — | — |
| 2021-03-31 | $0.00 | $-0.00 | — | — | — |
| 2020-12-31 | $0.00 | $-0.00 | — | — | — |
| 2020-09-30 | $0.00 | $-0.00 | — | — | — |
Frequently asked questions
Has Alterity Therapeutics Ltd beaten earnings estimates?
Alterity Therapeutics Ltd has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +100.0% over the last 3 quarters.
What is Alterity Therapeutics Ltd's revenue growth rate?
Alterity Therapeutics Ltd reported year-over-year revenue growth of +402.4% in its most recent quarter.